Patient and Physician Decisional Factors Regarding Hypercalcemia of Malignancy Treatment: A Novel Mixed-Methods Study
CONCLUSION: Using mixed methods, CPG developers can obtain meaningful information regarding evidence to decision criteria. In the case of HCM CPGs, this approach has provided the required contextual information and supported the development of evidence-based recommendations.PMID:36545699 | DOI:10.1210/clinem/dgac630
Source: The Journal of Clinical Endocrinology and Metabolism - Category: Endocrinology Authors: Aya Bassatne Mohammad H Murad Thomas Piggott Matthew T Drake Maya Rahme Ghada El-Hajj Fuleihan Source Type: research
More News: Cancer & Oncology | Databases & Libraries | Endocrinology | Reclast | Sensipar | Study | Xgeva | Zometa